Last reviewed: June 10, 2026
Last updated: June 10, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide and similar GLP-1 receptor agonists have become popular tools for weight management and metabolic improvement, with millions of prescriptions filled annually. If you're considering pregnancy or currently trying to conceive, knowing how these medications interact with fertility is critical for informed decision-making.
How GLP-1 Medications Affect Reproductive Health
GLP-1 drugs work by slowing stomach emptying and signaling fullness to your brain, leading to reduced appetite and weight loss. Weight loss itself can improve fertility outcomes in people with obesity, since excess body fat disrupts insulin sensitivity and hormone balance. Clinical evidence shows that 5–10% weight reduction can restore regular menstrual cycles and improve ovulation in individuals with polycystic ovary syndrome (PCOS), a leading cause of infertility.
However, the medications themselves are not designed for fertility enhancement. The FDA classifies semaglutide as Category C for pregnancy, meaning animal studies have shown some risk but human data is limited. Rapid weight loss during the first trimester—if pregnancy occurs while taking GLP-1 therapy—could theoretically reduce nutrient availability to a developing fetus, which is why timing and medical oversight matter.
Pregnancy Planning: When to Pause GLP-1 Treatment
Most fertility specialists recommend discontinuing GLP-1 medications at least one to three months before attempting conception. This waiting period allows your body to stabilize after the medication clears your system and ensures that any pregnancy achieved occurs on a drug-free baseline. Semaglutide has a half-life of about one week, so it typically leaves your system within 4–6 weeks, though individual variation exists.
If you become pregnant while on a GLP-1 medication, inform your obstetrician immediately. They may recommend stopping the drug to reduce any theoretical risk during early fetal development. The decision always involves weighing the benefits of continued weight management against potential unknowns. Maintaining the weight loss achieved through medication—via diet, exercise, and behavioral support—becomes the focus during pregnancy and lactation.
PCOS, Insulin Resistance, and GLP-1 Therapy
Polycystic ovary syndrome affects up to 10% of reproductive-age women and is strongly linked to insulin resistance and obesity. GLP-1 medications improve insulin sensitivity, which can help regulate the hormonal imbalances driving PCOS symptoms, including irregular periods and reduced fertility. Some research suggests that improved insulin control may restore ovulation and increase the chances of successful pregnancy.
For individuals with PCOS planning pregnancy, GLP-1 therapy may serve as a bridge to better metabolic health before conception. However, this strategy requires close coordination with both an endocrinologist and a fertility specialist to ensure the treatment plan supports your reproductive goals. PlexusDx Semaglutide Injection, available from licensed 503A compounding pharmacies, provides access to this therapy without insurance, starting at $149 per month, making metabolic optimization financially accessible.
Genetic Factors in Fertility and Metabolic Response
Individual responses to GLP-1 therapy vary significantly, and some of this variation is rooted in genetics. The PlexusDx Precision Peptide Genetic Test identifies variants in the GLP1R gene (rs6923761) and other metabolic pathways that influence how your body responds to semaglutide and tirzepatide. Understanding your genetic profile can help optimize treatment timing and dosing before conception.
The test also examines FTO rs9939609 and MC4R rs17782313 variants, which affect appetite regulation and weight management capacity. For someone planning pregnancy, knowing whether you carry variants associated with slower GLP-1 response or faster weight regain after discontinuation can inform whether you need a longer stabilization period before attempting conception. This personalized insight—available as a $99 add-on after your first month of treatment—supports more strategic family planning decisions.
Safety Considerations During Lactation
Limited data exists on whether GLP-1 medications pass into breast milk in clinically significant amounts. Most manufacturers recommend avoiding semaglutide and tirzepatide during breastfeeding as a precautionary measure, since adequate nutrition is essential for milk supply and infant health. If you're nursing and considering resuming GLP-1 therapy, consult your obstetrician and pediatrician to weigh individual risks and benefits.
Many individuals successfully maintain weight loss through postpartum dietary strategies and exercise before restarting GLP-1 medication after weaning. This approach prioritizes infant nutrition while allowing you to leverage the metabolic improvements achieved during your initial treatment course. Your healthcare provider can help you develop a timeline that aligns with your breastfeeding plan and long-term wellness goals.
Accessing Fertility-Aware GLP-1 Treatment
PlexusDx provides compounded semaglutide and tirzepatide from licensed 503A pharmacies across all 50 states, with no insurance requirement or membership fee. This accessibility makes it easier to start metabolic therapy and work with your fertility specialist on a synchronized timeline. Your dose may need to go up—your price won't—so you have financial predictability throughout your treatment.
HSA and FSA accounts are eligible for PlexusDx medications, further reducing out-of-pocket costs for family planning. If you're using multiple treatment modalities—fertility medications, metabolic therapy, and genetic testing—consolidating GLP-1 access through PlexusDx can simplify logistics and improve adherence. Start your journey with a consultation about how semaglutide or tirzepatide fits into your conception timeline.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I get pregnant while taking semaglutide?
Pregnancy is possible while on semaglutide, but most fertility specialists recommend stopping the medication at least 1–3 months before actively trying to conceive. If you do become pregnant while taking it, notify your obstetrician immediately for guidance on whether to discontinue. Your doctor will assess individual risk factors and help you make an informed decision.
Does GLP-1 therapy improve fertility outcomes?
GLP-1 medications do not directly enhance fertility, but weight loss achieved through these drugs can significantly improve reproductive outcomes in people with obesity or PCOS. Studies show that 5–10% weight reduction can restore regular ovulation and menstrual cycles. The fertility benefit comes from improved metabolic health, not from the drug itself.
How long should I wait after stopping semaglutide before trying to conceive?
Semaglutide typically clears your system within 4–6 weeks; most specialists recommend waiting 1–3 months to allow your body to fully stabilize. This timeframe also ensures that your baseline metabolic state and weight stabilize before conception, reducing variables that could affect early fetal development.
Can I take GLP-1 medication while breastfeeding?
Manufacturers recommend avoiding semaglutide and tirzepatide during breastfeeding due to limited safety data. Many individuals maintain weight loss through diet and exercise postpartum and resume GLP-1 therapy after weaning. Discuss your specific situation with your obstetrician and pediatrician for personalized guidance.
Does the PlexusDx Precision Peptide Genetic Test help with fertility planning?
Yes. The test identifies variants in GLP1R, FTO, and MC4R genes that influence your metabolic response to semaglutide and weight loss capacity. Understanding these genetic factors helps you and your fertility specialist time treatment discontinuation and predict how stable your weight loss will be during pregnancy planning, available as a $99 add-on after your first month of treatment.
Is PlexusDx semaglutide safe for someone planning pregnancy?
PlexusDx Semaglutide Injection comes from licensed 503A compounding pharmacies and is safe during the treatment phase. For pregnancy planning, discontinue the medication 1–3 months before conception with your doctor's guidance. At $149 per month, it's an affordable option for metabolic optimization before family planning.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Does Semaglutide Burn Fat? Insights into Its Role in Weight Loss and Fat Reduction
Do You Lose Weight the First Week on Tirzepatide?